Open surgical replacement of the descending thoracic and thoracoabdominal aorta in patients with confirmed Marfan and Loeys-Dietz syndromes: A 20-year single-centre experience.


Journal

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
ISSN: 1873-734X
Titre abrégé: Eur J Cardiothorac Surg
Pays: Germany
ID NLM: 8804069

Informations de publication

Date de publication:
03 08 2022
Historique:
received: 14 08 2021
revised: 03 02 2022
accepted: 26 02 2022
pubmed: 15 3 2022
medline: 23 9 2022
entrez: 14 3 2022
Statut: ppublish

Résumé

A relatively small proportion of patients with heritable thoracic aortic disease require open surgical replacement of the distal thoracic aorta. We reviewed the outcome in patients with Marfan and Loeys-Dietz syndromes treated in an aortic centre in the United Kingdom. We performed a single-centre retrospective study of consecutive patients treated between October 1999 and December 2019. The primary end point was 30-day mortality. Secondary end points were Kaplan-Meier estimates of medium-term survival and freedom from distal reintervention. Data are presented as median (interquartile range). A total of 58 patients [33 men; 51 with Marfan syndrome; median age 41 years (35-48); median aneurysm diameter 60 mm (55-74)] underwent open descending (n = 21) or thoracoabdominal aortic replacement (n = 37). All repairs were performed using cardiopulmonary bypass with hypothermic circulatory arrest in 31 patients. The 30-day mortality was 5.2% (n = 3, including 2 patients ≥ 60 years with significant comorbidity). Major non-fatal complications included early reoperation (n = 7), tracheostomy (n = 9), temporary renal replacement therapy (n = 3), permanent spinal cord deficit (n = 2) and permanent stroke (n = 1). Median follow-up was 81 months (48-127). Estimated (±standard error) 5-year survival was 85% ±5%. Seven patients had distal aortic reintervention with no deaths or spinal cord deficit: estimated 5-year freedom from distal reintervention was 94% ±3%. There was no difference in survival or freedom from distal reintervention comparing: elective vs. non-elective; type of heritable thoracic aortic disease; DeBakey type; or extent of surgical repair. Descending thoracic and thoracoabdominal aortic replacement in patients with heritable thoracic aortic disease can be performed with low perioperative morbidity and mortality, satisfactory long-term survival and low requirement for distal reintervention.

Identifiants

pubmed: 35285871
pii: 6548221
doi: 10.1093/ejcts/ezac137
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Donald Adam (D)

Departments of Cardiac and Vascular Surgery, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.

Mauro Iafrancesco (M)

Departments of Cardiac and Vascular Surgery, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.

Maciej Juszczak (M)

Departments of Cardiac and Vascular Surgery, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.

Martin Claridge (M)

Departments of Cardiac and Vascular Surgery, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.

David Quinn (D)

Departments of Cardiac and Vascular Surgery, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.

Eshan Senanayake (E)

Departments of Cardiac and Vascular Surgery, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.

Paul Clift (P)

Departments of Cardiac and Vascular Surgery, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.

Jorge Mascaro (J)

Departments of Cardiac and Vascular Surgery, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH